Growth Metrics

Indivior Pharmaceuticals (INDV) Amortizatization of Intangibles (2022 - 2026)

Indivior Pharmaceuticals has reported Amortizatization of Intangibles over the past 5 years, most recently at $2.0 million for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $2.0 million; the TTM value through Mar 2026 reached $10.0 million, down 16.67%, while the annual FY2025 figure was $10.0 million, 16.67% down from the prior year.
  • Amortizatization of Intangibles for Q1 2026 was $2.0 million at Indivior Pharmaceuticals, down from $3.0 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $4.0 million in Q3 2024 and troughed at -$6.0 million in Q4 2023.
  • A 5-year average of $1.9 million and a median of $2.0 million in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 400.0% in 2023 and later skyrocketed 300.0% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $2.0 million in 2022, then tumbled by 400.0% to -$6.0 million in 2023, then surged by 166.67% to $4.0 million in 2024, then dropped by 25.0% to $3.0 million in 2025, then crashed by 33.33% to $2.0 million in 2026.
  • Business Quant data shows Amortizatization of Intangibles for INDV at $2.0 million in Q1 2026, $3.0 million in Q4 2025, and $2.0 million in Q3 2025.